ro 19-3704 has been researched along with rp 59227 in 1 studies
Studies (ro 19-3704) | Trials (ro 19-3704) | Recent Studies (post-2010) (ro 19-3704) | Studies (rp 59227) | Trials (rp 59227) | Recent Studies (post-2010) (rp 59227) |
---|---|---|---|---|---|
14 | 0 | 0 | 11 | 1 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cavero, I; Floch, A; Sedivy, P; Tahraoui, L | 1 |
1 other study(ies) available for ro 19-3704 and rp 59227
Article | Year |
---|---|
The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.
Topics: Animals; Azepines; Glyceryl Ethers; Guinea Pigs; Humans; Luminescent Measurements; Macrophages; Male; Neutrophils; Oxygen; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridines; Radioligand Assay; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thiazoles; Triazoles | 1991 |